NCT07279701 The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access
| NCT ID | NCT07279701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brno University Hospital |
| Condition | Intravenous Cannulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-12-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if using near-infrared imaging in pediatric vein cannulation is leading to higher success rate. The main question it aims to answer is: is there higher success of first attempt in periferal vein cannulation? does it lower overall number of attempts to successful cannulation?
Eligibility Criteria
Inclusion Criteria: * Pediatric patients admitted to the inpatient section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital * Pediatric patients in the anesthesia section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital * Indicated insertion of peripheral venous access * Consent of the patient/legal representative to the study Exclusion Criteria: * Disagreement with the study * Not indicated insertion of peripheral venous access (according to clinical condition and decision of the attending physician) * A device for near-infrared imaging of the venous bed is not available
Contact & Investigator
Petr Štourač, prof, MD, PhD
PRINCIPAL INVESTIGATOR
Brno University Hospital
Frequently Asked Questions
Who can join the NCT07279701 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, up to 19 Years, studying Intravenous Cannulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07279701 currently recruiting?
Yes, NCT07279701 is actively recruiting participants. Contact the research team at harazim.hana@fnbrno.cz for enrollment information.
Where is the NCT07279701 trial being conducted?
This trial is being conducted at Brno, Czechia.
Who is sponsoring the NCT07279701 clinical trial?
NCT07279701 is sponsored by Brno University Hospital. The principal investigator is Petr Štourač, prof, MD, PhD at Brno University Hospital. The trial plans to enroll 200 participants.